Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.23.3
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 27, 2023
Aug. 18, 2023
Jul. 19, 2023
Jun. 26, 2023
Jun. 22, 2023
Jun. 16, 2023
Jun. 15, 2023
Jun. 01, 2023
May 24, 2023
Jan. 26, 2023
May 31, 2020
Sep. 30, 2023
Sep. 28, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Stockholders’ Equity [Line Items]                                  
Convertable preferred shares                       45,000,000     45,000,000   45,000,000
Stock issued during period, restricted shares     14,340                            
Stock issued during period shares                         1,410,807        
Stock issued value in lieu of settlement of accounts payable (in Dollars)                       $ 71,978   $ 66,874 $ 116,145 $ 151,874  
Per share fair value (in Dollars per share) $ 0.19                                
Common stock purchase agreement (in Dollars)                         $ 311,220   $ 572,906 $ 725,050  
Warrants issued to purchase of common stock             823,078       169,409 415,000     415,000    
Warrants exercise price (in Dollars per share)             $ 0.65       $ 4            
Equity financing (in Dollars)                     $ 565,000            
Equity financing (in Dollars)                       $ 125,000     $ 125,000   $ 125,000
Unvested stock options and restricted stock awards (in Dollars)                       $ 25,070     $ 25,070   $ 222,000
Common Stock [Member]                                  
Stockholders’ Equity [Line Items]                                  
Stock issued during period, restricted shares           216,667       11,332   14,340   36,332 242,339 107,998  
Stock issued during period shares 118,643 131,000   72,548 48,948   228,568   102,096     322,191   90,804 473,235 174,758  
Stock issued value in lieu of settlement of accounts payable (in Dollars) $ 22,542 $ 32,750   $ 16,686 $ 17,621       $ 26,545     $ 322   $ 91 $ 473 $ 175  
Per share fair value (in Dollars per share)   $ 0.25   $ 0.23 $ 0.36       $ 0.26                
Common Stock Purchase Agreement [Member]                                  
Stockholders’ Equity [Line Items]                                  
Stock issued during period shares         300,000     300,000                  
Common stock purchase agreement (in Dollars)         $ 134,634     $ 127,053                  
Equity Financing Member [Member]                                  
Stockholders’ Equity [Line Items]                                  
Common stock purchase agreement (in Dollars)                     $ 515,000            
Price per share (in Dollars per share)                     $ 3.8            
Series A Convertible Preferred Stock [Member]                                  
Stockholders’ Equity [Line Items]                                  
Authorized shares                       900,000     900,000   900,000
Authorized per share (in Dollars per share)                       $ 0.001     $ 0.001   $ 0.001
Accounts Payable [Member]                                  
Stockholders’ Equity [Line Items]                                  
Stock issued during period shares                     135,527